Clofarabine is yet to be named in any RAC patent. I've got a list saved somewhere, there's >30 named synergy opportunities, but Clo is not (yet) one.
I don't expect RAC to comment on the (not so) surprising lack of cardiotoxicity observed at Sheba 2.0 until Nagler publishes the data in a journal*.
*Still hanging out for the Dominissini Data!
Cardioprotection thread, page-868
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.68 |
Change
-0.030(1.75%) |
Mkt cap ! $286.2M | |||
| Open | High | Low | Value | Volume |
| $1.73 | $1.73 | $1.68 | $119.9K | 70.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3012 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 6382 | 1 |
View Market Depth
| Last trade - 15.07pm 03/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |